Embecta Corp (EMBC)
13.93
-0.27
(-1.90%)
USD |
NASDAQ |
May 20, 16:00
13.93
0.00 (0.00%)
After-Hours: 17:39
Embecta 1 Year Total Returns (Daily): -46.58% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | -46.58% |
| May 16, 2024 | -49.12% |
| May 15, 2024 | -50.51% |
| May 14, 2024 | -50.84% |
| May 13, 2024 | -52.26% |
| May 10, 2024 | -50.26% |
| May 09, 2024 | -49.99% |
| May 08, 2024 | -63.82% |
| May 07, 2024 | -62.62% |
| May 06, 2024 | -63.18% |
| May 03, 2024 | -63.90% |
| May 02, 2024 | -62.67% |
| May 01, 2024 | -63.82% |
| April 30, 2024 | -62.28% |
| April 29, 2024 | -61.13% |
| April 26, 2024 | -61.06% |
| April 25, 2024 | -61.16% |
| April 24, 2024 | -60.89% |
| April 23, 2024 | -61.84% |
| April 22, 2024 | -62.40% |
| April 19, 2024 | -62.44% |
| April 18, 2024 | -62.66% |
| April 17, 2024 | -62.66% |
| April 16, 2024 | -62.06% |
| April 15, 2024 | -61.18% |
| Date | Value |
|---|---|
| April 12, 2024 | -62.72% |
| April 11, 2024 | -61.04% |
| April 10, 2024 | -59.21% |
| April 09, 2024 | -56.93% |
| April 08, 2024 | -55.77% |
| April 05, 2024 | -53.54% |
| April 04, 2024 | -51.73% |
| April 03, 2024 | -52.07% |
| April 02, 2024 | -53.26% |
| April 01, 2024 | -51.83% |
| March 28, 2024 | -52.75% |
| March 27, 2024 | -56.31% |
| March 26, 2024 | -57.99% |
| March 25, 2024 | -57.38% |
| March 22, 2024 | -56.23% |
| March 21, 2024 | -56.80% |
| March 20, 2024 | -55.11% |
| March 19, 2024 | -55.46% |
| March 18, 2024 | -53.83% |
| March 15, 2024 | -54.45% |
| March 14, 2024 | -52.37% |
| March 13, 2024 | -50.22% |
| March 12, 2024 | -53.10% |
| March 11, 2024 | -53.10% |
| March 08, 2024 | -53.85% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-63.90%
Minimum
May 03 2024
16.00%
Maximum
May 16 2023
-34.40%
Average
-42.56%
Median
1 Year Total Returns (Daily) Benchmarks
| AIM ImmunoTech Inc | -19.40% |
| Perspective Therapeutics Inc | 252.7% |
| Protalix BioTherapeutics Inc | -51.69% |
| Electromed Inc | 32.31% |
| Armata Pharmaceuticals Inc | 107.2% |